EIGR
Vanguard Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,201
| Closed | -$141K | – | 4502 |
|
|
2024
Q1 | $141K | Sell |
28,201
-1,792,566
| -98% | -$8.97M | ﹤0.01% | 4213 |
|
|
2023
Q4 | $409K | Sell |
1,820,767
-143,535
| -7% | -$32.2K | ﹤0.01% | 4093 |
|
|
2023
Q3 | $599K | Hold |
1,964,302
| – | – | ﹤0.01% | 4002 |
|
|
2023
Q2 | $1.38M | Sell |
1,964,302
-204,102
| -9% | -$144K | ﹤0.01% | 3796 |
|
|
2023
Q1 | $1.94M | Buy |
2,168,404
+105,783
| +5% | +$94.9K | ﹤0.01% | 3679 |
|
|
2022
Q4 | $2.43M | Buy |
2,062,621
+32,038
| +2% | +$37.8K | ﹤0.01% | 3595 |
|
|
2022
Q3 | $15.3M | Buy |
2,030,583
+111,247
| +6% | +$838K | ﹤0.01% | 2747 |
|
|
2022
Q2 | $12.1M | Buy |
1,919,336
+230,093
| +14% | +$1.45M | ﹤0.01% | 2885 |
|
|
2022
Q1 | $14M | Sell |
1,689,243
-8,278
| -0.5% | -$68.7K | ﹤0.01% | 2970 |
|
|
2021
Q4 | $8.81M | Buy |
1,697,521
+996
| +0.1% | +$5.17K | ﹤0.01% | 3288 |
|
|
2021
Q3 | $11.3M | Buy |
1,696,525
+11,397
| +0.7% | +$76.1K | ﹤0.01% | 3166 |
|
|
2021
Q2 | $14.4M | Buy |
1,685,128
+57,390
| +4% | +$489K | ﹤0.01% | 3018 |
|
|
2021
Q1 | $14.4M | Buy |
1,627,738
+37,125
| +2% | +$329K | ﹤0.01% | 2956 |
|
|
2020
Q4 | $19.5M | Buy |
1,590,613
+263,591
| +20% | +$3.24M | ﹤0.01% | 2643 |
|
|
2020
Q3 | $10.8M | Buy |
1,327,022
+30,117
| +2% | +$245K | ﹤0.01% | 2747 |
|
|
2020
Q2 | $12.5M | Buy |
1,296,905
+24,425
| +2% | +$234K | ﹤0.01% | 2657 |
|
|
2020
Q1 | $8.65M | Buy |
1,272,480
+70,982
| +6% | +$483K | ﹤0.01% | 2682 |
|
|
2019
Q4 | $17.9M | Buy |
1,201,498
+87,686
| +8% | +$1.31M | ﹤0.01% | 2585 |
|
|
2019
Q3 | $11.4M | Buy |
1,113,812
+42,898
| +4% | +$440K | ﹤0.01% | 2746 |
|
|
2019
Q2 | $11.4M | Buy |
1,070,914
+300,279
| +39% | +$3.18M | ﹤0.01% | 2786 |
|
|
2019
Q1 | $10.8M | Buy |
770,635
+49,736
| +7% | +$695K | ﹤0.01% | 2786 |
|
|
2018
Q4 | $7.32M | Buy |
720,899
+270,443
| +60% | +$2.75M | ﹤0.01% | 2923 |
|
|
2018
Q3 | $5.41M | Buy |
450,456
+21,000
| +5% | +$252K | ﹤0.01% | 3205 |
|
|
2018
Q2 | $5.24M | Buy |
429,456
+151,077
| +54% | +$1.84M | ﹤0.01% | 3203 |
|
|
2018
Q1 | $2.74M | Buy |
278,379
+99,161
| +55% | +$977K | ﹤0.01% | 3353 |
|
|
2017
Q4 | $2.5M | Buy |
179,218
+82,100
| +85% | +$1.15M | ﹤0.01% | 3358 |
|
|
2017
Q3 | $1.07M | Sell |
97,118
-3,219
| -3% | -$35.4K | ﹤0.01% | 3576 |
|
|
2017
Q2 | $792K | Sell |
100,337
-47,735
| -32% | -$377K | ﹤0.01% | 3624 |
|
|
2017
Q1 | $1.7M | Buy |
148,072
+2,269
| +2% | +$26K | ﹤0.01% | 3429 |
|
|
2016
Q4 | $1.7M | Sell |
145,803
-649
| -0.4% | -$7.56K | ﹤0.01% | 3409 |
|
|
2016
Q3 | $1.96M | Buy |
146,452
+21,665
| +17% | +$290K | ﹤0.01% | 3402 |
|
|
2016
Q2 | $2.47M | Buy |
124,787
+90,659
| +266% | +$1.8M | ﹤0.01% | 3297 |
|
|
2016
Q1 | $573K | Sell |
34,128
-469,583
| -93% | -$7.88M | ﹤0.01% | 3753 |
|
|
2015
Q4 | $740K | Buy |
503,711
+5,282
| +1% | +$7.76K | ﹤0.01% | 3718 |
|
|
2015
Q3 | $524K | Buy |
498,429
+40,683
| +9% | +$42.8K | ﹤0.01% | 3841 |
|
|
2015
Q2 | $576K | Buy |
457,746
+164,717
| +56% | +$207K | ﹤0.01% | 3830 |
|
|
2015
Q1 | $5.55M | Buy |
293,029
+59,265
| +25% | +$1.12M | ﹤0.01% | 2944 |
|
|
2014
Q4 | $4.57M | Buy |
233,764
+35,426
| +18% | +$692K | ﹤0.01% | 2944 |
|
|
2014
Q3 | $2.08M | Buy |
198,338
+87,770
| +79% | +$918K | ﹤0.01% | 3246 |
|
|
2014
Q2 | $1.77M | Buy |
110,568
+9,726
| +10% | +$156K | ﹤0.01% | 3312 |
|
|
2014
Q1 | $1.2M | Buy |
+100,842
| New | +$1.2M | ﹤0.01% | 3397 |
|